- In August 2020, Dr Reddy's Laboratories announced the launch of a generic version of Ciprodex for the treatment of ear infections in the US. This first-to-market generic version exemplifies the firm's commitment to bringing affordable generic medicines to market for patients
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Acute Otitis Media, Otitis Media with Effusion, Chronic Otitis Media with Effusion), Indication (Otitis, Middle Ear Infections, Others), Drug Class (Cerumenolytics, Otic Anesthetics, Otic Anti-Infectives, Otic Steroids, Others), Route of Administration (Oral, Topical and Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Otic Drugs Market size was valued at USD 1.77 USD Billion in 2024.
The Global Otic Drugs Market is projected to grow at a CAGR of 6.45% during the forecast period of 2025 to 2032.
The major players operating in the market include Eli Lilly and Company ,AstraZeneca ,Novartis AG ,Johnson &, Johnson Private Limited ,Teva Pharmaceutical Industries Ltd. ,Merck &, Co.Inc. ,Allergan ,Bausch Health Companies Inc. ,Abbott ,F. Hoffmann-La Roche Ltd. ,Pfizer Inc. ,GlaxoSmithKline plc ,Sanofi ,Merck KGaA ,Dr. Reddy',s Laboratories Ltd. ,Zydus Cadila ,Sun Pharmaceutical Industries Ltd. ,Aurobindo Pharma ,Lupin ,Hikma Pharmaceuticals PLC .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
